canakinumab
novartis
['canakinumab']
#acr22 hyperigd syndrome (hids/mkd)
-attack duration 3-7day
-onset first year of life
-seen in dutch, northern european
-mvk mutations
-canakinumab
-can have nl igd levels
Doctor, wife, mother. avid #CLE fan. Working at doing it all and keeping sane! tweet primarily rheum and primary care issues of interest. opinions are mine